Variant report

Variant	nsv1041356
Chromosome Location	chr10:54136199-54200432
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:235)
CpG islands
(count:244)
Chromatin interactive
region (count:31)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:235 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr10:54151854-54152011	HepG2	liver:	n/a	n/a
2	BHLHE40	chr10:54196919-54197295	GM12878	blood:	n/a	n/a
3	BHLHE40	chr10:54137814-54138087	HepG2	liver:	n/a	chr10:54137897-54137918 chr10:54137904-54137913
4	BHLHE40	chr10:54159642-54159726	GM12878	blood:	n/a	n/a
5	BRCA1	chr10:54159646-54159717	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr10:54137925-54138270	HepG2	liver:	n/a	chr10:54138127-54138138
7	CEBPB	chr10:54183222-54183554	IMR90	lung:	n/a	n/a
8	CEBPB	chr10:54137962-54138183	A549	lung:	n/a	chr10:54138127-54138138
9	CEBPB	chr10:54184061-54184376	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr10:54138028-54138221	HepG2	liver:	n/a	chr10:54138127-54138138
11	CEBPB	chr10:54195008-54195801	MCF-7	breast:	n/a	n/a
12	CEBPB	chr10:54183208-54183529	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr10:54137968-54138310	HepG2	liver:	n/a	chr10:54138127-54138138
14	CEBPB	chr10:54142962-54143167	HepG2	liver:	n/a	chr10:54143027-54143038 chr10:54143028-54143039
15	CEBPB	chr10:54137942-54138319	HepG2	liver:	n/a	chr10:54138127-54138138
16	CEBPB	chr10:54137993-54138284	H1-hESC	embryonic stem cell:	n/a	chr10:54138127-54138138
17	CEBPB	chr10:54168907-54169458	MCF-7	breast:	n/a	n/a
18	CEBPB	chr10:54195243-54195429	H1-hESC	embryonic stem cell:	n/a	n/a
19	CEBPB	chr10:54168997-54169412	MCF-7	breast:	n/a	n/a
20	CEBPB	chr10:54195047-54195584	MCF-7	breast:	n/a	n/a
21	CHD2	chr10:54150312-54150345	K562	blood:	n/a	n/a
22	CTCF	chr10:54137440-54137590	Caco-2	colon:	n/a	n/a
23	CTCF	chr10:54143755-54143841	GM20000	blood:	n/a	n/a
24	CTCF	chr10:54200380-54200530	HRPEpiC	eye:	n/a	n/a
25	CTCF	chr10:54194774-54194849	GM10248	blood:	n/a	n/a
26	CTCF	chr10:54171750-54171842	GM10248	blood:	n/a	n/a
27	CTCF	chr10:54200380-54200530	MCF-7	breast:	n/a	n/a
28	CTCF	chr10:54191749-54191864	HepG2	liver:	n/a	n/a
29	CTCF	chr10:54200411-54200529	MCF-7	breast:	n/a	n/a
30	CTCF	chr10:54191720-54191870	HepG2	liver:	n/a	n/a
31	CTCF	chr10:54191740-54191890	HepG2	liver:	n/a	n/a
32	CTCF	chr10:54191711-54191925	HepG2	liver:	n/a	n/a
33	CTCF	chr10:54200424-54200553	MCF-7	breast:	n/a	n/a
34	CTCF	chr10:54194546-54194690	MCF-7	breast:	n/a	n/a
35	CTCF	chr10:54200340-54200490	HMF	breast:	n/a	n/a
36	CTCF	chr10:54200404-54200539	Gliobla	brain:	n/a	n/a
37	CTCF	chr10:54194556-54194646	MCF-7	breast:	n/a	n/a
38	CTCF	chr10:54194547-54194656	MCF-7	breast:	n/a	n/a
39	CTCF	chr10:54200411-54200510	Hela-S3	cervix:	n/a	n/a
40	CTCF	chr10:54200320-54200470	BE2_C	brain:	n/a	n/a
41	CTCF	chr10:54200180-54200330	HRE	kidney:	n/a	n/a
42	CTCF	chr10:54194562-54194671	MCF-7	breast:	n/a	n/a
43	CTCF	chr10:54194778-54194787	A549	lung:	n/a	n/a
44	CUX1	chr10:54141528-54141591	GM12878	blood:	n/a	n/a
45	E2F4	chr10:54170033-54170181	MCF10A-Er-Src	breast:	n/a	n/a
46	EBF1	chr10:54197000-54197274	GM12878	blood:	n/a	n/a
47	EBF1	chr10:54181837-54181880	GM12878	blood:	n/a	n/a
48	EP300	chr10:54138778-54139048	SK-N-SH_RA	brain:	n/a	n/a
49	EP300	chr10:54137651-54138453	HepG2	liver:	n/a	chr10:54137851-54137865 chr10:54137793-54137807
50	EP300	chr10:54147333-54148122	ECC-1	luminal epithelium:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:54172718-54172768	Caco-2	colon:	n/a
2	chr10:54166783-54166833	GM12878	blood:	n/a
3	chr10:54166783-54166833	T-47D	breast:	n/a
4	chr10:54170977-54171027	MCF-7	breast:	n/a
5	chr10:54166783-54166833	ovcar-3	ovarian:	n/a
6	chr10:54170977-54171027	MCF10A-Er-Src	breast:	n/a
7	chr10:54170977-54171027	HAEpiC	amniotic membrane:	n/a
8	chr10:54166783-54166833	HEK293	kidney:	embryo
9	chr10:54170977-54171027	Hepatocyte	liver:	n/a
10	chr10:54166783-54166833	H1-hESC	embryonic stem cell:	embryo
11	chr10:54172718-54172768	GM19239	blood:	n/a
12	chr10:54166783-54166833	NT2-D1	testis:	n/a
13	chr10:54170977-54171027	NT2-D1	testis:	n/a
14	chr10:54170977-54171027	SK-N-SH	brain:	n/a
15	chr10:54172718-54172768	PrEC	prostate:	n/a
16	chr10:54170928-54170978	HCF	heart:	n/a
17	chr10:54170977-54171027	Jurkat	blood:	n/a
18	chr10:54172718-54172768	HCPEpiC	choroid plexus:	n/a
19	chr10:54172718-54172768	HRPEpiC	eye:	n/a
20	chr10:54170977-54171027	ovcar-3	ovarian:	n/a
21	chr10:54172718-54172768	HMEC	breast:	n/a
22	chr10:54170977-54171027	HMEC	breast:	n/a
23	chr10:54170977-54171027	U87	brain:	n/a
24	chr10:54170977-54171027	BJ	skin:	n/a
25	chr10:54170928-54170978	HAEpiC	amniotic membrane:	n/a
26	chr10:54170928-54170978	GM12878	blood:	n/a
27	chr10:54172718-54172768	AG09319	gingival:	n/a
28	chr10:54166783-54166833	HPAEpiC	pulmonary alveolar:	n/a
29	chr10:54170928-54170978	SK-N-SH	brain:	n/a
30	chr10:54170928-54170978	AoSMC	blood vessel:	n/a
31	chr10:54172718-54172768	HRE	kidney:	n/a
32	chr10:54172718-54172768	BJ	skin:	n/a
33	chr10:54170928-54170978	PANC-1	pancreas:	n/a
34	chr10:54172718-54172768	Jurkat	blood:	n/a
35	chr10:54170928-54170978	GM12891	blood:	n/a
36	chr10:54170928-54170978	Hela-S3	cervix:	n/a
37	chr10:54166783-54166833	MCF-7	breast:	n/a
38	chr10:54166783-54166833	AoSMC	blood vessel:	n/a
39	chr10:54170977-54171027	PFSK-1	brain:	n/a
40	chr10:54172718-54172768	NT2-D1	testis:	n/a
41	chr10:54170928-54170978	HPAEpiC	pulmonary alveolar:	n/a
42	chr10:54170977-54171027	GM19239	blood:	n/a
43	chr10:54172718-54172768	HAEpiC	amniotic membrane:	n/a
44	chr10:54170977-54171027	HRPEpiC	eye:	n/a
45	chr10:54170928-54170978	BE2_C	brain:	n/a
46	chr10:54172718-54172768	K562	blood:	n/a
47	chr10:54170977-54171027	HCPEpiC	choroid plexus:	n/a
48	chr10:54170928-54170978	T-47D	breast:	n/a
49	chr10:54170928-54170978	GM19239	blood:	n/a
50	chr10:54172718-54172768	H1-hESC	embryonic stem cell:	embryo

(count:31 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:54149526..54151091-chr10:54155620..54157632,2	K562	blood:
2	chr10:54168310..54170304-chr10:54200960..54203183,2	MCF-7	breast:
3	chr10:54071490..54075450-chr10:54149766..54152641,3	MCF-7	breast:
4	chr10:54170977..54173585-chr10:54198985..54203167,3	MCF-7	breast:
5	chr10:54189947..54192723-chr10:54198135..54200639,2	MCF-7	breast:
6	chr10:54170977..54173585-chr10:54198985..54203167,3	MCF-7	breast:
7	chr10:54071324..54082180-chr10:54192987..54217560,81	MCF-7	breast:
8	chr10:54073917..54074819-chr10:54199961..54201295,3	MCF-7	breast:
9	chr10:54200285..54201097-chr10:54248304..54249598,4	MCF-7	breast:
10	chr10:54073088..54075340-chr10:54178301..54179879,2	MCF-7	breast:
11	chr10:54176138..54178606-chr10:54181975..54183926,2	K562	blood:
12	chr10:54111958..54114420-chr10:54199763..54201853,2	MCF-7	breast:
13	chr10:54200035..54202312-chr10:54233699..54236085,2	MCF-7	breast:
14	chr10:54194863..54196960-chr10:54232017..54234172,2	MCF-7	breast:
15	chr10:54075730..54077425-chr10:54167077..54169136,2	MCF-7	breast:
16	chr10:54194382..54199261-chr10:54199441..54202196,4	MCF-7	breast:
17	chr10:54189947..54192723-chr10:54198135..54200639,2	MCF-7	breast:
18	chr10:54189103..54191771-chr10:54192378..54194470,2	MCF-7	breast:
19	chr10:54092984..54095026-chr10:54166953..54169179,2	MCF-7	breast:
20	chr10:54149526..54151091-chr10:54155620..54157632,2	K562	blood:
21	chr10:54077521..54079030-chr10:54180923..54182792,2	MCF-7	breast:
22	chr10:54136741..54139715-chr10:54150116..54153046,2	MCF-7	breast:
23	chr10:54129947..54132591-chr10:54167991..54170801,2	MCF-7	breast:
24	chr10:54072676..54075890-chr10:54175491..54177804,3	MCF-7	breast:
25	chr10:54145859..54147775-chr10:54203869..54205399,2	MCF-7	breast:
26	chr10:54176138..54178606-chr10:54181975..54183926,2	K562	blood:
27	chr10:54065577..54083492-chr10:54193846..54218961,120	MCF-7	breast:
28	chr10:54194382..54199261-chr10:54199441..54202196,4	MCF-7	breast:
29	chr10:54136741..54139715-chr10:54150116..54153046,2	MCF-7	breast:
30	chr10:54189103..54191771-chr10:54192378..54194470,2	MCF-7	breast:
31	chr10:54073525..54075924-chr10:54146848..54149629,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MBL2-9	chr10:54148872-54149248	NONHSAT013425
2	lnc-MBL2-5	chr10:54185076-54185175	NONHSAT013417
3	lnc-MBL2-5	chr10:54185072-54185097	l_313_chr10:53986797-54185097_lymphNode

No data

Variant related genes	Relation type
ENSG00000213657	TF binding region
PRKRIRP3	TF binding region
ENSG00000213657	CpG island
PRKRIRP3	CpG island
ENSG00000107984	chromatin interactions
ENSG00000236671	chromatin interactions

Extended variants
information (count: 2530 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:2530 , 50 per page) page: 1 2 3 4 5 6 7 ... 51

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4935035	chr10:54136199-54136200	Enhancers Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs149095170	chr10:54136272-54136273	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs142210193	chr10:54136282-54136283	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs151232066	chr10:54136333-54136334	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs112157525	chr10:54136349-54136350	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs551844132	chr10:54136361-54136362	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs185693340	chr10:54136402-54136403	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs545280762	chr10:54136404-54136405	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs190059140	chr10:54136409-54136410	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs528771737	chr10:54136450-54136451	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs551797397	chr10:54136493-54136494	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs180919005	chr10:54136528-54136529	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs200137344	chr10:54136562-54136563	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs140397381	chr10:54136575-54136576	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs550797513	chr10:54136598-54136599	Weak transcription Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs373217431	chr10:54136638-54136639	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs567390582	chr10:54136732-54136733	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs535282058	chr10:54136737-54136738	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs527665670	chr10:54136780-54136781	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs555124857	chr10:54136830-54136831	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs572057800	chr10:54136844-54136845	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs547737617	chr10:54136892-54136893	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs534605572	chr10:54136901-54136902	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs557993782	chr10:54136924-54136925	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs185186673	chr10:54136997-54136998	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs543378024	chr10:54137022-54137023	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs145190069	chr10:54137045-54137046	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs573765107	chr10:54137074-54137075	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs567535403	chr10:54137135-54137136	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs371287663	chr10:54137153-54137154	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs543271466	chr10:54137219-54137220	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs559983568	chr10:54137272-54137273	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs528834873	chr10:54137329-54137330	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs137893639	chr10:54137366-54137367	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs140868349	chr10:54137402-54137403	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs72789124	chr10:54137405-54137406	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs550915781	chr10:54137427-54137428	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs567453572	chr10:54137466-54137467	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs112821580	chr10:54137531-54137532	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs556349362	chr10:54137544-54137545	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs191127785	chr10:54137597-54137598	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs377368693	chr10:54137609-54137610	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs79617788	chr10:54137617-54137618	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs534770858	chr10:54137652-54137653	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs557789326	chr10:54137667-54137668	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs183976648	chr10:54137730-54137731	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs188530743	chr10:54137742-54137743	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs536683032	chr10:54137751-54137752	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs72789125	chr10:54137759-54137760	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs573826778	chr10:54137797-54137798	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	18632612	CNVD
Autism	18414403	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
T-cell lymphomas	19863542	CNVD
Testicular germ cell tumor	18059402	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Obesity	21956041	CNVD
Developmental delay	21948486	CNVD
Dysmorphic features	21948486	CNVD
Epilepsy	21948486	CNVD
Intellectual disability	21948486	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Colorectal cancer	16272173	CNVD
Metanephric adenoma	20802469	CNVD
Autism	20841430	CNVD
Mental retardation	17124404	CNVD
Epilepsy	20923578	CNVD
Prostate cancer	16573809	CNVD
Schizophrenia	19329560	CNVD
Heart failure	18772530	CNVD
Heart failure	18854381	CNVD
Hyperglycemia	19060297	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Glioblastoma multiforme	22286061	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Usher syndrome	20538994	CNVD
Glioblastoma multiforme	17002787	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:159 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:54134800-54136200	Enhancers	Pancreas	Pancrea
2	chr10:54135800-54136800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr10:54135800-54137200	Enhancers	Fetal Intestine Large	intestine
4	chr10:54135800-54137200	Enhancers	Fetal Intestine Small	intestine
5	chr10:54136000-54136200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr10:54136000-54136200	Enhancers	HUES48 Cell Line	embryonic stem cell
7	chr10:54136000-54136200	Flanking Active TSS	HepG2	liver
8	chr10:54136000-54136400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
9	chr10:54136000-54136600	Enhancers	HUES6 Cell Line	embryonic stem cell
10	chr10:54136000-54136800	Enhancers	iPS-15b Cell Line	embryonic stem cell
11	chr10:54136000-54137000	Enhancers	Duodenum Mucosa	Duodenum
12	chr10:54136000-54137200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
13	chr10:54136000-54137400	Enhancers	Stomach Mucosa	stomach
14	chr10:54136200-54136400	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
15	chr10:54136200-54136600	Enhancers	HepG2	liver
16	chr10:54136200-54136800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
17	chr10:54136200-54136800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
18	chr10:54136600-54137000	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
19	chr10:54136600-54138000	Flanking Active TSS	HepG2	liver
20	chr10:54136600-54138200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
21	chr10:54136600-54138800	Enhancers	A549	lung
22	chr10:54136800-54137000	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr10:54136800-54137600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
24	chr10:54136800-54137600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
25	chr10:54136800-54139400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
26	chr10:54137000-54138800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr10:54137200-54138000	Weak transcription	Fetal Intestine Large	intestine
28	chr10:54137200-54138600	Weak transcription	Fetal Intestine Small	intestine
29	chr10:54137200-54142400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
30	chr10:54137400-54138800	Weak transcription	Stomach Mucosa	stomach
31	chr10:54138000-54139400	Enhancers	Fetal Intestine Large	intestine
32	chr10:54138000-54139400	Enhancers	HepG2	liver
33	chr10:54138600-54139200	Enhancers	Fetal Intestine Small	intestine
34	chr10:54138800-54139400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr10:54138800-54139400	Enhancers	Stomach Mucosa	stomach
36	chr10:54138800-54139400	Flanking Active TSS	A549	lung
37	chr10:54138800-54139400	Enhancers	HUVEC	blood vessel
38	chr10:54139400-54142400	Weak transcription	HepG2	liver
39	chr10:54139400-54142600	Weak transcription	A549	lung
40	chr10:54141200-54141600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr10:54142400-54143000	Enhancers	HepG2	liver
42	chr10:54142400-54143400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
43	chr10:54142600-54143200	Enhancers	A549	lung
44	chr10:54143200-54147400	Weak transcription	A549	lung
45	chr10:54145400-54147400	Weak transcription	HSMM	muscle
46	chr10:54146400-54148400	Enhancers	HUVEC	blood vessel
47	chr10:54146400-54149200	Enhancers	HMEC	breast
48	chr10:54147200-54148400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr10:54147200-54148600	Enhancers	NHEK	skin
50	chr10:54147400-54147800	Enhancers	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links